FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE | N210493 | HELSINN HEALTHCARE SA
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2025-00946 | 9186357 | IPR | AZURITY PHARMACEUTICALS, INC. | Trial Instituted | 2025-05-01 | 2025-11-19 |
| IPR2025-00947 | 9186357 | IPR | AZURITY PHARMACEUTICALS, INC. | Trial Instituted | 2025-05-01 | 2025-11-19 |
| IPR2025-00949 | 10828297 | IPR | AZURITY PHARMACEUTICALS, INC. | Trial Instituted | 2025-05-01 | 2025-11-19 |
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
HELSINN HEALTHCARE S.A. v. GLAND PHARMA LIMITED 10 patentsANDA 217374fosnetupitant chloride hydrochloride / palonosetron hydrochloride | D.N.J. | 2022-07-18 | Terminated 2022-12-23 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8426450 | May 23, 2032 | — | Yes | Yes | — | — |
| 8895586 | May 23, 2032 | — | — | — | — | |
| 9186357 | Nov 18, 2030 | — | — | — | — | |
| 9403772 | May 23, 2032 | — | Yes | — | — | |
| 9908907 | May 23, 2032 | — | Yes | Yes | — | — |
| 10208073 | May 23, 2032 | — | — | — | — | |
| 10624911 | Jun 2, 2037 | — | — | Yes | — | — |
| 10717721 | May 23, 2032 | — | Yes | — | — | — |
| 10828297 | Dec 17, 2030 | — | — | — | — | |
| 11312698 | May 23, 2032 | — | Yes | Yes | — | — |
| 11529362 | Jun 2, 2037 | — | — | Yes | — | — |
| 12208109 | Jun 2, 2037 | — | — | Yes | — | — |